A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma

Author: Ezughah Francesca   Dawe Robert   Ibbotson Sally   Fleming Colin  

Publisher: Informa Healthcare

ISSN: 1471-1753

Source: Journal of Dermatological Treatment, Vol.19, Iss.2, 2008-01, pp. : 111-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content